Newsroom

Press Releases

October 22, 2026Business WireSofusa Holdings Relaunches as Independent Company to Advance Lymphatic Drug DeliveryRead release

Empower the Lymphatics

Team Press Releases Publications

Sofusa Holdings is developing investigational technologies for lymphatic imaging and targeted drug delivery. Unless otherwise stated, products described on this website are under development and have not been approved or cleared by the U.S. Food and Drug Administration for commercial use.

© 2026 Sofusa HoldingsPrivacy · Terms